GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » G.Barekat Pharm (XTEH:BRKT1) » Definitions » Common Stock

G.Barekat Pharm (XTEH:BRKT1) Common Stock : IRR3,400,000 Mil (As of Mar. 2017)


View and export this data going back to 2017. Start your Free Trial

What is G.Barekat Pharm Common Stock?

G.Barekat Pharm's quarterly common stock stayed the same from . 20 (IRR0 Mil) to Mar. 2016 (IRR0 Mil) but then increased from Mar. 2016 (IRR0 Mil) to Mar. 2017 (IRR3,400,000 Mil).

G.Barekat Pharm's annual common stock stayed the same from . 20 (IRR0 Mil) to Mar. 2016 (IRR0 Mil) but then increased from Mar. 2016 (IRR0 Mil) to Mar. 2017 (IRR3,400,000 Mil).

G.Barekat Pharm Common Stock Historical Data

The historical data trend for G.Barekat Pharm's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

G.Barekat Pharm Common Stock Chart

G.Barekat Pharm Annual Data
Trend Mar16 Mar17
Common Stock
- 3,400,000.00

G.Barekat Pharm Semi-Annual Data
Mar16 Mar17
Common Stock - 3,400,000.00

G.Barekat Pharm Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

G.Barekat Pharm (XTEH:BRKT1) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » G.Barekat Pharm (XTEH:BRKT1) » Definitions » Common Stock
Comparable Companies
PRGBQ BOM:532041 PZRXQ NSPX HSTC BOM:540108 XCNQ:ZRO XSAT:EURI B BOM:524604 BOM:532905 VODG BOM:506365 SOAN TSXV:WAVE PTEO BPSR CBBT LSE:PEBI ADYNF NTRR
Traded in Other Exchanges
N/A
Address
No. 11, 5th Alley, Bucharest Avenue, Argentina Square, Tehran, IRN
Website
http://www.bpharmed.com
G.Barekat Pharm focuses on the introduction of new pharmaceutical fields such as biotechnology, drug delivery which includes nanotechnology, slow release drugs, and new technologies for health, development of cellular molecular industries like tuberculosis, gene therapy, immunotherapy, and tissue technology.

G.Barekat Pharm (XTEH:BRKT1) Headlines

No Headlines